5. FEJEZET | Vérzéscsillapító szerek
Steven W. Pipe¹ | Manuel Carcao² | Kim Chew³ | Radoslaw Kaczmarek⁴ | Steve Kitchen⁵ | Johnny Mahlangu⁶ | Margareth C. Ozelo⁷ | Ekawat Suwantaroj⁸ | Jerzy Windyga⁹ | Glenn F. Pierce¹⁰ | Alok Srivastava¹¹
¹Departments of Pediatrics and Pathology, University of Michigan, Ann Arbor, Michigan, USA
²Department of Paediatrics, University of Toronto, Division of Haematology/Oncology, Hospital for Sick Children, Toronto, ON, Canada
³Kuala Lumpur, Malaysia
⁴Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA
⁵Department of Coagulation, Sheffield Haemophilia and Thrombosis Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
⁶Department of Molecular Medicine and Haematology, University of the Witwatersrand, National Health Laboratory Service, Johannesburg, South Africa
⁷INCT do Sangue Hemocentro UNICAMP, University of Campinas, Campinas, SP, Brazil
⁸Bangkok, Thailand
⁹Department of Hemostasis Disorders and Internal Medicine, Laboratory of Hemostasis and Metabolic Diseases, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
¹⁰World Federation of Hemophilia, Montreal, QC, Canada
¹¹Department of Haematology, Christian Medical College, Vellore, IndiaAz összes ajánlásként megjelölt állítás konszenzuson alapul, CB jelöléssel.